A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report

Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study

(2020) Fang-Xiao Zhu et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of thrombotic events in patients with immune thrombocytopenia

(2019) Shoko Ito et al.   ANNALS OF HEMATOLOGY

Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist–oncologists

(2018) Allyson M. Pishko et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score

(2018) Amaris K. Balitsky et al.   BLOOD

Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study

(2018) Nicoletta Machin et al.   THROMBOSIS RESEARCH

Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis

(2016) Indraraj Umesh Doobaree et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies

(2016) Wendy J. Langeberg et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

(2014) M. Ruggeri et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: Results from a retrospective cohort study

(2014) Elena Ramírez et al.   THROMBOSIS RESEARCH

Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia

(2013) S. Boyle et al.   BLOOD

Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies

(2013) Ki-Jo Kim et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immune Thrombocytopenia Patients Requiring Anticoagulation—Maneuvering Between Scylla and Charybdis

(2013) Axel Matzdorff et al.   SEMINARS IN HEMATOLOGY

Use of Glucocorticoids and Risk of Venous Thromboembolism

(2013) Sigrun A. Johannesdottir et al.   JAMA Internal Medicine

Antiphospholipid antibodies: Evaluation of the thrombotic risk

(2012) Katrien M.J. Devreese   THROMBOSIS RESEARCH

Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study

(2010) R. W. THOMSEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

(2009) Maria G. Tektonidou et al.   ARTHRITIS AND RHEUMATISM

The ITP syndrome: pathogenic and clinical diversity

(2009) D. B. Cines et al.   BLOOD

Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients

(2007) Joseph E. Spahr et al.   AMERICAN JOURNAL OF HEMATOLOGY